Generate Biomedicines, Inc. · NASDAQ:GENB
Flagship Pioneering, LLC reported a 48.90% stake in Generate Biomedicines, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Flagship Pioneering, LLC reported a 48.90% stake in Generate Biomedicines, Inc., 62,673,117 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 48.90%
- Shares
- 62,673,117
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 15 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Flagship Pioneering Fund VI, L.P. | 9.90% | 12,723,940 |
| Flagship Pioneering Fund VI General Partner LLC | 9.90% | 12,723,940 |
| Pioneering Medicines 02, LLC | 1.20% | 1,562,500 |
| Flagship Pioneering Fund VII, L.P. | 13.10% | 16,827,224 |
| Flagship Pioneering Fund VII General Partner LLC | 13.10% | 16,827,224 |
| Nutritional Health LTP Fund, L.P. | 0.80% | 987,491 |
| Nutritional Health LTP Fund General Partner LLC | 0.80% | 987,491 |
| Flagship Pioneering Special Opportunities Fund II, L.P. | 2.20% | 2,777,752 |
| Flagship Pioneering Special Opportunities Fund II General Partner LLC | 2.20% | 2,777,752 |
| FPN II, L.P. | 3.40% | 4,340,252 |
| FPN General Partner LLC | 3.40% | 4,340,252 |
| Flagship VentureLabs VI, LLC | 19.50% | 25,016,458 |
| Flagship VentureLabs VI Manager LLC | 19.50% | 25,016,458 |
| Flagship Pioneering, LLC | 48.90% | 62,673,117 |
| Afeyan Noubar | 48.90% | 62,701,915 |